tiprankstipranks
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
US Market
SION
Sionna Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see SION full AI Analyst Report?

Sionna Therapeutics, Inc. (SION) Stock Forecast & Price Target

31 Followers
See the Price Targets and Ratings of:

SION Analyst Ratings

Moderate Buy
9Ratings
Moderate Buy
7 Buy
1 Hold
1 Sell
Based on 9 analysts giving stock ratings to
Sionna
Therapeutics, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SION Stock 12 Month Forecast

Average Price Target

$53.14
▲(16.29% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Sionna Therapeutics, Inc. in the last 3 months. The average price target is $53.14 with a high forecast of $63.00 and a low forecast of $23.00. The average price target represents a 16.29% change from the last price of $45.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"$15","64":"$64","27.25":"$27.3","39.5":"$39.5","51.75":"$51.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$63.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":53.14285714285714,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$53.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,27.25,39.5,51.75,64],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.13,48.35076923076923,49.571538461538466,50.792307692307695,52.01307692307692,53.23384615384616,54.45461538461539,55.675384615384615,56.89615384615385,58.11692307692308,59.33769230769231,60.55846153846154,61.77923076923077,{"y":63,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.13,47.59252747252747,48.05505494505495,48.51758241758242,48.980109890109894,49.44263736263736,49.90516483516483,50.36769230769231,50.83021978021978,51.29274725274725,51.755274725274724,52.21780219780219,52.68032967032967,{"y":53.14285714285714,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.13,45.27384615384616,43.41769230769231,41.56153846153846,39.70538461538462,37.84923076923077,35.99307692307693,34.13692307692308,32.28076923076923,30.424615384615386,28.56846153846154,26.712307692307693,24.85615384615385,{"y":23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.92,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.39,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.47,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.21,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.96,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.14,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.65,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.92,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.3,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.15,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.9,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.64,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.13,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$63.00Average Price Target$53.14Lowest Price Target$23.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guggenheim Analyst forecast on SION
Yatin Suneja
Guggenheim
Guggenheim
$50→$60
Buy
31.29%
Upside
Reiterated
08/06/26
Sionna Therapeutics price target raised to $60 from $50 at GuggenheimSionna Therapeutics price target raised to $60 from $50 at Guggenheim
BTIG Analyst forecast on SION
Kambiz Yazdi
BTIG
BTIG
$58
Buy
26.91%
Upside
Reiterated
08/06/26
BTIG Reaffirms Their Buy Rating on Sionna Therapeutics, Inc. (SION)
LifeSci Capital Analyst forecast on SION
Gaurav Maini
LifeSci Capital
LifeSci Capital
$60
Buy
31.29%
Upside
Reiterated
08/06/26
Buy Rating Reiterated on Sionna Ahead of Key CF Data Readouts; $60 Price Target Maintained
TD Cowen Analyst forecast on SION
Ritu Baral
TD Cowen
TD Cowen
―
Buy
―
Reiterated
07/17/26
Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst
JonesTrading Analyst forecast on SION
Debanjana Chatterjee
JonesTrading
JonesTrading
$63
Buy
37.86%
Upside
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (NASDAQ: SION) and Janux Therapeutics Inc (NASDAQ: JANX)
Stifel Nicolaus Analyst forecast on SION
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$55
Buy
20.35%
Upside
Reiterated
05/25/26
Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)
Freedom Capital Markets Analyst forecast on SION
Ilya Zubkov
Freedom Capital Markets
Freedom Capital Markets
―
Hold
―
Downgraded
05/20/26
Sionna Therapeutics downgraded to Hold from Buy at Freedom BrokerSionna Therapeutics downgraded to Hold from Buy at Freedom Broker
Wedbush Analyst forecast on SION
Laura Chico
Wedbush
Wedbush
$53
Buy
15.97%
Upside
Reiterated
05/18/26
Wedbush Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)
RBC Capital Analyst forecast on SION
Brian Abrahams
RBC Capital
RBC Capital
$24→$23
Sell
-49.67%
Downside
Reiterated
05/12/26
RBC Capital Sticks to Its Sell Rating for Sionna Therapeutics, Inc. (SION)
Citizens JMP Analyst forecast on SION
Jonathan Wolleben
Citizens JMP
Citizens JMP
$63
Buy
37.86%
Upside
Initiated
02/24/26
Sionna Therapeutics initiated with an Outperform at CitizensSionna Therapeutics initiated with an Outperform at Citizens
Raymond James Analyst forecast on SION
Unknown Analyst
Raymond James
Not Ranked
Raymond James
$30.91→$45
Buy
-1.53%
Downside
Reiterated
10/16/25
Sionna Therapeutics, Inc. (SION) Gets a Buy from Raymond James
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guggenheim Analyst forecast on SION
Yatin Suneja
Guggenheim
Guggenheim
$50→$60
Buy
31.29%
Upside
Reiterated
08/06/26
Sionna Therapeutics price target raised to $60 from $50 at GuggenheimSionna Therapeutics price target raised to $60 from $50 at Guggenheim
BTIG Analyst forecast on SION
Kambiz Yazdi
BTIG
BTIG
$58
Buy
26.91%
Upside
Reiterated
08/06/26
BTIG Reaffirms Their Buy Rating on Sionna Therapeutics, Inc. (SION)
LifeSci Capital Analyst forecast on SION
Gaurav Maini
LifeSci Capital
LifeSci Capital
$60
Buy
31.29%
Upside
Reiterated
08/06/26
Buy Rating Reiterated on Sionna Ahead of Key CF Data Readouts; $60 Price Target Maintained
TD Cowen Analyst forecast on SION
Ritu Baral
TD Cowen
TD Cowen
―
Buy
―
Reiterated
07/17/26
Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst
JonesTrading Analyst forecast on SION
Debanjana Chatterjee
JonesTrading
JonesTrading
$63
Buy
37.86%
Upside
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (NASDAQ: SION) and Janux Therapeutics Inc (NASDAQ: JANX)
Stifel Nicolaus Analyst forecast on SION
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$55
Buy
20.35%
Upside
Reiterated
05/25/26
Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)
Freedom Capital Markets Analyst forecast on SION
Ilya Zubkov
Freedom Capital Markets
Freedom Capital Markets
―
Hold
―
Downgraded
05/20/26
Sionna Therapeutics downgraded to Hold from Buy at Freedom BrokerSionna Therapeutics downgraded to Hold from Buy at Freedom Broker
Wedbush Analyst forecast on SION
Laura Chico
Wedbush
Wedbush
$53
Buy
15.97%
Upside
Reiterated
05/18/26
Wedbush Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)
RBC Capital Analyst forecast on SION
Brian Abrahams
RBC Capital
RBC Capital
$24→$23
Sell
-49.67%
Downside
Reiterated
05/12/26
RBC Capital Sticks to Its Sell Rating for Sionna Therapeutics, Inc. (SION)
Citizens JMP Analyst forecast on SION
Jonathan Wolleben
Citizens JMP
Citizens JMP
$63
Buy
37.86%
Upside
Initiated
02/24/26
Sionna Therapeutics initiated with an Outperform at CitizensSionna Therapeutics initiated with an Outperform at Citizens
Raymond James Analyst forecast on SION
Unknown Analyst
Raymond James
Not Ranked
Raymond James
$30.91→$45
Buy
-1.53%
Downside
Reiterated
10/16/25
Sionna Therapeutics, Inc. (SION) Gets a Buy from Raymond James
Stocks with the Highest Top Analyst Consensus in the General Sector
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
CBRSCerebras Systems, Inc. Class A
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sionna Therapeutics, Inc.

3 Months
Ritu BaralTD Cowen
Success Rate
8/8 ratings generated profit
100%
Average Return
+31.67%
Copying Ritu Baral's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +31.67% per trade.
1 Year
Ritu BaralTD Cowen
Success Rate
8/8 ratings generated profit
100%
Average Return
+113.47%
Copying Ritu Baral's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +113.47% per trade.
2 Years
Ritu BaralTD Cowen
Success Rate
8/8 ratings generated profit
100%
Average Return
+144.81%
Copying Ritu Baral's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +144.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SION Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
7
5
4
3
3
Buy
5
15
14
16
7
Hold
0
1
1
1
0
Sell
1
2
1
1
0
Strong Sell
0
0
0
0
0
total
13
23
20
21
10
In the current month, SION has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SION average Analyst price target in the past 3 months is 53.14.
Each month's total comprises the sum of three months' worth of ratings.

SION Financial Forecast

SION Earnings Forecast

Next quarter’s earnings estimate for SION is -$0.64 with a range of -$0.86 to -$0.53. The previous quarter’s EPS was -$0.66. SION beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 34.11% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.
Next quarter’s earnings estimate for SION is -$0.64 with a range of -$0.86 to -$0.53. The previous quarter’s EPS was -$0.66. SION beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 34.11% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.
No data currently available

SION Sales Forecast

Next quarter’s sales forecast for SION is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. SION beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 31.80% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.
Next quarter’s sales forecast for SION is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. SION beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 31.80% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.

SION Stock Forecast FAQ

What is SION’s average 12-month price target, according to analysts?
Based on analyst ratings, Sionna Therapeutics, Inc.’s 12-month average price target is 53.14.
    What is SION’s upside potential, based on the analysts’ average price target?
    Sionna Therapeutics, Inc. has 16.29% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SION a Buy, Sell or Hold?
          Sionna Therapeutics, Inc. has a consensus rating of Moderate Buy which is based on 7 buy ratings, 1 hold ratings and 1 sell ratings.
            What is Sionna Therapeutics, Inc.’s price target?
            The average price target for Sionna Therapeutics, Inc. is 53.14. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $63.00 ,the lowest forecast is $23.00. The average price target represents 16.29% Increase from the current price of $45.7.
              What do analysts say about Sionna Therapeutics, Inc.?
              Sionna Therapeutics, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of SION?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.